JP2016537010A5 - - Google Patents

Download PDF

Info

Publication number
JP2016537010A5
JP2016537010A5 JP2016540920A JP2016540920A JP2016537010A5 JP 2016537010 A5 JP2016537010 A5 JP 2016537010A5 JP 2016540920 A JP2016540920 A JP 2016540920A JP 2016540920 A JP2016540920 A JP 2016540920A JP 2016537010 A5 JP2016537010 A5 JP 2016537010A5
Authority
JP
Japan
Prior art keywords
subject
luminal
breast cancer
biological sample
subtype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016540920A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016537010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/054760 external-priority patent/WO2015035377A1/en
Publication of JP2016537010A publication Critical patent/JP2016537010A/ja
Publication of JP2016537010A5 publication Critical patent/JP2016537010A5/ja
Pending legal-status Critical Current

Links

JP2016540920A 2013-09-09 2014-09-09 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット Pending JP2016537010A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361875373P 2013-09-09 2013-09-09
US61/875,373 2013-09-09
US201461990948P 2014-05-09 2014-05-09
US61/990,948 2014-05-09
PCT/US2014/054760 WO2015035377A1 (en) 2013-09-09 2014-09-09 Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy

Publications (2)

Publication Number Publication Date
JP2016537010A JP2016537010A (ja) 2016-12-01
JP2016537010A5 true JP2016537010A5 (enExample) 2017-09-14

Family

ID=51688397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016540920A Pending JP2016537010A (ja) 2013-09-09 2014-09-09 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット

Country Status (7)

Country Link
US (1) US20150072021A1 (enExample)
EP (1) EP3044332A1 (enExample)
JP (1) JP2016537010A (enExample)
AU (1) AU2014317843A1 (enExample)
CA (1) CA2923166A1 (enExample)
IL (1) IL244421A0 (enExample)
WO (1) WO2015035377A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198972A1 (en) 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
PL2297359T4 (pl) 2008-05-30 2014-07-31 Univ North Carolina Chapel Hill Profile ekspresji genów do przewidywania skutków raka piersi
SG11201704177SA (en) 2014-11-24 2017-06-29 Nanostring Technologies Inc Methods and apparatuses for gene purification and imaging
JP2018500895A (ja) * 2014-12-09 2018-01-18 キングス・カレッジ・ロンドン タキサン療法による乳癌治療
MX2018005867A (es) * 2015-11-13 2018-09-21 Biotheranostics Inc Integracion de las caracteristicas tumorales con el indice de cancer de mama.
KR102456433B1 (ko) 2016-03-02 2022-10-19 에자이 알앤드디 매니지먼트 가부시키가이샤 에리불린-기반 항체-약물 콘주게이트 및 사용 방법
CN107574243B (zh) * 2016-06-30 2021-06-29 博奥生物集团有限公司 分子标志物、内参基因及其应用、检测试剂盒以及检测模型的构建方法
CN108456730B (zh) * 2018-02-27 2021-01-05 海门善准生物科技有限公司 一种复发风险基因群作为标志物在制备评估乳腺癌分子分型内远处复发风险的产品中的应用
US12352750B2 (en) 2019-04-04 2025-07-08 University Of Utah Research Foundation Multigene assay to assess risk of recurrence of cancer
KR102414754B1 (ko) * 2019-10-10 2022-06-30 주식회사 종근당 직장암 항암화학방사선 치료 반응 예측용 바이오마커
TW202129008A (zh) * 2019-11-05 2021-08-01 香港商行動基因(智財)有限公司 檢測異檸檬酸脫氫酶突變的套組及方法
EP3945136A1 (en) * 2020-07-28 2022-02-02 Hospital Clínic de Barcelona In vitro method for the prognosis of patients suffering from her2-positive breast cancer
CN113278700B (zh) * 2021-06-04 2022-08-09 浙江省肿瘤医院 一种用于乳腺癌分型及预后预测的引物组及试剂盒
KR20240081508A (ko) 2022-11-17 2024-06-10 인제대학교 산학협력단 Dna 메틸화 변화를 통한 방사선치료 반응성 예측용 바이오마커 조성물 및 이의 용도
CN116622885B (zh) * 2023-05-23 2025-01-10 福建省农业科学院果树研究所 一种用于不同桃花色鉴定的分子标记方法及其应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
CA2118806A1 (en) 1991-09-18 1993-04-01 William J. Dower Method of synthesizing diverse collections of oligomers
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
AU675054B2 (en) 1991-11-22 1997-01-23 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
DE69829402T2 (de) 1997-10-31 2006-04-13 Affymetrix, Inc. (a Delaware Corp.), Santa Clara Expressionsprofile in adulten und fötalen organen
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
WO2006010150A2 (en) 2004-07-15 2006-01-26 University Of Utah Research Foundation Housekeeping genes and methods for identifying the same
EP1954708A4 (en) 2005-11-23 2009-05-13 Univ Utah Res Found Methods and compositions involving intrinsic genes
JP5700911B2 (ja) 2005-12-23 2015-04-15 ナノストリング テクノロジーズ,インコーポレーテッド 配向され、固定化された巨大分子を含む組成物とその製造法
EP1963531B1 (en) 2005-12-23 2011-09-21 Nanostring Technologies, Inc. Nanoreporters and methods of manufacturing and use thereof
US7892740B2 (en) * 2006-01-19 2011-02-22 The University Of Chicago Prognosis and therapy predictive markers and methods of use
CA2687292C (en) 2007-04-10 2017-07-04 Nanostring Technologies, Inc. Methods and computer systems for identifying target-specific sequences for use in nanoreporters
EP2195467B1 (en) * 2007-09-06 2016-12-14 bioTheranostics, Inc. Tumor grading and cancer prognosis in breast cancer
JP2010539890A (ja) * 2007-09-14 2010-12-24 ユニヴァーシティ オブ サウス フロリダ 放射線治療の応答を予測するための遺伝子シグネチャー
PL2297359T4 (pl) 2008-05-30 2014-07-31 Univ North Carolina Chapel Hill Profile ekspresji genów do przewidywania skutków raka piersi
ES2614810T3 (es) 2008-08-14 2017-06-02 Nanostring Technologies, Inc Nanoindicadores estables
EP2785873A4 (en) * 2011-11-30 2015-11-11 Univ North Carolina METHOD FOR THE TREATMENT OF BREAST CANCER WITH TAXAN THERAPY
IN2014MN02418A (enExample) * 2012-05-22 2015-08-14 Nanostring Technologies Inc

Similar Documents

Publication Publication Date Title
JP2016537010A5 (enExample)
Das et al. Biomarkers in cancer detection, diagnosis, and prognosis
JP2010538609A5 (enExample)
ES2730384T3 (es) Puntuación de la infiltración linfocitaria de los tumores
ES2550192T3 (es) Biomarcadores para el cáncer de pulmón
Arnedos et al. Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial
JP2016174600A5 (enExample)
Stav et al. Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma
JP2014514278A5 (enExample)
JP2017503481A5 (enExample)
WO2013052480A1 (en) Marker-based prognostic risk score in colon cancer
CN106148529B (zh) 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用
Gerashchenko et al. Intratumoral morphological heterogeneity of breast cancer as an indicator of the metastatic potential and tumor chemosensitivity
JP2018527886A5 (enExample)
JP2015210268A5 (enExample)
ES2877689T3 (es) miARN circulantes como marcador de detección temprana y marcador pronóstico
JP2018512160A5 (enExample)
US20120244531A1 (en) Method for providing information for diagnosing cancer using quantitative real-time pcr and kit for diagnosing cancer for the same
JP2017516501A5 (enExample)
JP2022009848A (ja) 扁平上皮がんに対する化学放射線療法の有効性を評価するための方法
Chuthapisith et al. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women
JP2011527575A5 (enExample)
Kim et al. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
Li et al. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma
Zhou et al. Increased expression of long non-coding RNA SBDSP1 correlates with poor survival in colorectal cancer